PROTEIN PHOSPHATASE 2A INHIBITORS FOR TREATING MYELODYSPLASTIC SYNDROMES
摘要
Disclosed are methods for treating a meylodysplastic syndrome (MDS) in a subject that involves administering to the subject a therapeutically effective amount of a protein phosphatase 2A (PP2A) inhibitor.
申请公布号
WO2016014783(A1)
申请公布日期
2016.01.28
申请号
WO2015US41714
申请日期
2015.07.23
申请人
H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.;LIXTE BIOTECHNOLOGY INC.
